Trial Profile
Phase II trial of NTC-801 in patients with atrial fibrillation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs NTC 801 (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 14 Dec 2015 New trial record